TASSAN MAZZOCCO, MARGHERITA
 Distribuzione geografica
Continente #
EU - Europa 202
NA - Nord America 141
AS - Asia 123
OC - Oceania 4
AF - Africa 2
SA - Sud America 2
Totale 474
Nazione #
US - Stati Uniti d'America 135
IT - Italia 93
SG - Singapore 68
RU - Federazione Russa 30
IE - Irlanda 22
DE - Germania 18
HK - Hong Kong 16
CN - Cina 14
FI - Finlandia 14
IN - India 12
GB - Regno Unito 9
CA - Canada 6
ID - Indonesia 5
KR - Corea 5
SE - Svezia 5
AU - Australia 4
BE - Belgio 4
FR - Francia 4
EG - Egitto 2
ES - Italia 2
BR - Brasile 1
JP - Giappone 1
NL - Olanda 1
PK - Pakistan 1
TW - Taiwan 1
UY - Uruguay 1
Totale 474
Città #
Singapore 64
Dublin 22
Santa Clara 17
Ashburn 16
Hong Kong 16
Milan 15
Frankfurt am Main 14
New York 12
Helsinki 8
Brescia 7
Melzo 7
Naples 7
Ahmedabad 6
Chicago 6
London 6
Beijing 5
Padova 5
Shanghai 5
Verdellino 5
Brussels 4
Cagliari 4
Decatur 4
Lappeenranta 4
New Haven 4
Ottawa 4
Palermo 4
Piacenza 4
Bellinzago Lombardo 3
Busto Arsizio 3
Jakarta 3
Alessandria 2
Carini 2
Castello di Brianza 2
Espoo 2
Faches-Thumesnil 2
Gothenburg 2
Jouy-le-Moutier 2
Marburg 2
Murcia 2
Richmond 2
Solna 2
Toronto 2
Turin 2
Washington 2
Yeongdeungpo-gu 2
Zagazig 2
Anyang-si 1
Austin 1
Bologna 1
Castelbuono 1
Chang-hua 1
Chennai 1
Como 1
Dortmund 1
Guwahati 1
Hackney 1
Kolkata 1
Los Angeles 1
Mapo-gu 1
Mizoram 1
Montecchio Maggiore 1
Montevideo 1
Multan 1
Perth 1
Pound Ridge 1
San Jose 1
Seattle 1
Semarang 1
Southwark 1
São Paulo 1
Tokyo 1
Yogyakarta 1
Zhuhai 1
Totale 343
Nome #
Identification of imaging biomarkers for neurodegenerative disorders: a comparative pre-clinical study in selected animal models 85
Exploring the neuroprotective effects of montelukast on brain inflammation and metabolism in a rat model of quinolinic acid-induced striatal neurotoxicity 78
Magnetic Resonance Imaging for neuronal degeneration evaluation in a Parkinson’s disease transgenic mouse model 65
Exploring The Neuroprotective Effects Of Montelukast Treatment In A Rat Model Of Quinolinic Acid-Induced Neurotoxicity 50
Evaluation of prodromal markers of degeneration in a Parkinson’s disease mouse model using PET-CT imaging 43
Application of reduction and refinement principles in the evaluation of prodromal markers of Parkinson’s disease in a progressive neurotoxic mouse model using multi-tracer PET imaging 37
Neuroprotective effects of Montelukast treatment in a rat model of Huntington-like neurotoxicity: a PET covariance study 34
Positive relation between dopamine neuron degeneration and metabolic connectivity disruption in the MPTP plus probenecid mouse model of Parkinson's disease 34
Dysfunction of the serotonergic system in the brain of synapsin triple knockout mice is associated with behavioral abnormalities resembling synapsin-related human pathologies 31
New brain atlas tool for Parkinson’s disease brain analysis 30
Investigating age-dependent modifications in mouse brain metabolic connectivity 13
null 5
null 5
Totale 510
Categoria #
all - tutte 3.152
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.152


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202391 0 0 0 0 0 0 0 17 29 11 17 17
2023/2024212 2 3 12 11 21 32 37 31 25 11 8 19
2024/2025207 25 47 54 38 33 10 0 0 0 0 0 0
Totale 510